Table 3.
Time since diagnosis | ||||||||
---|---|---|---|---|---|---|---|---|
< 2 years | 2–4.99 years | 5–9.99 years | 10+ years | |||||
n | % | n | % | n | % | n | % | |
Total N, % of total | 412 | 15.2 | 525 | 19.3 | 779 | 28.7 | 1001 | 36.8 |
Type of cancer | ||||||||
Breast | 148 | 12.0 | 237 | 19.2 | 365 | 29.6 | 483 | 39.2 |
Colorectal | 72 | 15.2 | 87 | 18.5 | 136 | 28.9 | 176 | 37.4 |
Genitourinary | 14 | 20.0 | 16 | 22.9 | 22 | 31.4 | 18 | 25.7 |
Gynecologic | 43 | 12.7 | 60 | 17.7 | 93 | 27.3 | 144 | 42.3 |
Lung | 15 | 22.7 | 9 | 13.6 | 25 | 37.9 | 17 | 27.8 |
Hematopoietic | 23 | 31.1 | 24 | 32.4 | 15 | 20.3 | 12 | 16.2 |
Lymphoma | 25 | 23.4 | 17 | 15.9 | 35 | 32.7 | 30 | 28.0 |
Other GI | 10 | 32.3 | 4 | 12.9 | 8 | 25.8 | 9 | 29.0 |
Skin | 25 | 18.0 | 30 | 21.6 | 41 | 29.5 | 43 | 30.9 |
Other | 37 | 19.9 | 41 | 22.0 | 39 | 21.0 | 69 | 37.1 |
Stage | ||||||||
In situ | 43 | 12.7 | 76 | 22.4 | 100 | 29.5 | 120 | 35.4 |
Local | 220 | 13.3 | 312 | 18.9 | 487 | 29.4 | 635 | 38.4 |
Regional | 88 | 17.5 | 85 | 16.9 | 139 | 27.6 | 191 | 40.0 |
Distant | 46 | 28.2 | 44 | 27.0 | 39 | 23.9 | 34 | 20.9 |
Unknown | 15 | 25.9 | 8 | 13.8 | 14 | 24.1 | 21 | 36.2 |
First course of therapy, % of total | ||||||||
Surgery | 353 | 85.7 | 475 | 90.5 | 733 | 94.1 | 952 | 95.1 |
Chemotherapy | 79 | 19.2 | 127 | 24.2 | 137 | 17.6 | 122 | 12.2 |
Radiation therapy | 96 | 23.3 | 113 | 21.5 | 185 | 23.8 | 151 | 15.1 |
Subsequent cancer diagnosis, % of total | 16 | 3.9 | 46 | 8.8 | 121 | 15.5 | 192 | 19.2 |
Reported current cancer treatment, % of total | 108 | 26.2 | 107 | 20.4 | 55 | 7.1 | 52 | 5.2 |